These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 28643587)
41. Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States. Kobelt G; Berg J; Atherly D; Hadjimichael O Neurology; 2006 Jun; 66(11):1696-702. PubMed ID: 16769943 [TBL] [Abstract][Full Text] [Related]
42. Burden and cost of multiple sclerosis in Brazil. Kobelt G; Teich V; Cavalcanti M; Canzonieri AM PLoS One; 2019; 14(1):e0208837. PubMed ID: 30673707 [TBL] [Abstract][Full Text] [Related]
43. The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs. Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T; Palmer AJ Mult Scler Relat Disord; 2020 Sep; 44():102247. PubMed ID: 32554286 [TBL] [Abstract][Full Text] [Related]
44. Social/economic costs and quality of life in patients with haemophilia in Europe. Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G; Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374 [TBL] [Abstract][Full Text] [Related]
45. Cost of multiple sclerosis in the Czech Republic: the COMS study. Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424 [TBL] [Abstract][Full Text] [Related]
46. Health status and costs of ambulatory patients with multiple sclerosis in Hungary. Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217 [TBL] [Abstract][Full Text] [Related]
47. Societal costs of multiple sclerosis in Ireland. Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900 [TBL] [Abstract][Full Text] [Related]
48. The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK. Orme M; Kerrigan J; Tyas D; Russell N; Nixon R Value Health; 2007; 10(1):54-60. PubMed ID: 17261116 [TBL] [Abstract][Full Text] [Related]
49. Direct and indirect economic consequences of multiple sclerosis in Ireland. Fogarty E; Walsh C; McGuigan C; Tubridy N; Barry M Appl Health Econ Health Policy; 2014 Dec; 12(6):635-45. PubMed ID: 25227118 [TBL] [Abstract][Full Text] [Related]
50. Economic evaluation of multiple sclerosis in the UK, Germany and France. Murphy N; Confavreux C; Haas J; König N; Roullet E; Sailer M; Swash M; Young C; Mérot JL; Pharmacoeconomics; 1998 May; 13(5 Pt 2):607-22. PubMed ID: 17165327 [TBL] [Abstract][Full Text] [Related]
51. Impact on healthcare resource utilization of multiple sclerosis in Spain. Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493 [TBL] [Abstract][Full Text] [Related]
52. Economic burden of multiple sclerosis in a population with low physical disability. García-Domínguez JM; Maurino J; Martínez-Ginés ML; Carmona O; Caminero AB; Medrano N; Ruíz-Beato E; BMC Public Health; 2019 May; 19(1):609. PubMed ID: 31109317 [TBL] [Abstract][Full Text] [Related]
53. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom. Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P; BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740 [TBL] [Abstract][Full Text] [Related]
54. Cost and health related quality of life consequences of multiple sclerosis. Grima DT; Torrance GW; Francis G; Rice G; Rosner AJ; Lafortune L Mult Scler; 2000 Apr; 6(2):91-8. PubMed ID: 10773854 [TBL] [Abstract][Full Text] [Related]
55. Burden of a multiple sclerosis relapse: the patient's perspective. Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP Patient; 2012; 5(1):57-69. PubMed ID: 22217263 [TBL] [Abstract][Full Text] [Related]
56. [Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life]. Ganzinger U; Badelt C; Vass K; Strasser-Fuchs S; Fazekas F; Berger T; Dahlke F Nervenarzt; 2004 Oct; 75(10):1000-6. PubMed ID: 15150646 [TBL] [Abstract][Full Text] [Related]
57. Social/economic costs and health-related quality of life in patients with scleroderma in Europe. López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G; Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626 [TBL] [Abstract][Full Text] [Related]
58. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries. Karampampa K; Gustavsson A; Miltenburger C; Eckert B Mult Scler; 2012 Jun; 18(2 Suppl):7-15. PubMed ID: 22623122 [TBL] [Abstract][Full Text] [Related]
59. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients. Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130 [TBL] [Abstract][Full Text] [Related]
60. Multiple sclerosis in the UK: service use, costs, quality of life and disability. McCrone P; Heslin M; Knapp M; Bull P; Thompson A Pharmacoeconomics; 2008; 26(10):847-60. PubMed ID: 18793032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]